Cargando…
Risperidone Associated Paralytic Ileus in Schizophrenia
A 32-year-old man, diagnosed with catatonic schizophrenia, was treated with risperidone and lorazepam in the general hospital psychiatry setup. He developed signs of intestinal obstruction, which was diagnosed as paralytic ileus and was treated conservatively along with stopping the offending drug....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701367/ https://www.ncbi.nlm.nih.gov/pubmed/23833349 http://dx.doi.org/10.4103/0253-7176.112214 |
_version_ | 1782275628585713664 |
---|---|
author | Ramamourthy, Parthasarathy Kumaran, Arunkumar Kattimani, Shivanand |
author_facet | Ramamourthy, Parthasarathy Kumaran, Arunkumar Kattimani, Shivanand |
author_sort | Ramamourthy, Parthasarathy |
collection | PubMed |
description | A 32-year-old man, diagnosed with catatonic schizophrenia, was treated with risperidone and lorazepam in the general hospital psychiatry setup. He developed signs of intestinal obstruction, which was diagnosed as paralytic ileus and was treated conservatively along with stopping the offending drug. Risperidone is said to be devoid of anticholinergic side effects, but prevalence of these varies from 7% to 13% in patients receiving treatment for schizophrenia. Constipation has been reported but fatal adverse effect like paralytic ileus with risperidone is rarely reported. Timely diagnosis can save the need for surgical interventions and fatal complications. This predisposition in schizophrenia could be due to neurodevelopmentally shared abnormality of brain and gut nervous system. |
format | Online Article Text |
id | pubmed-3701367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-37013672013-07-05 Risperidone Associated Paralytic Ileus in Schizophrenia Ramamourthy, Parthasarathy Kumaran, Arunkumar Kattimani, Shivanand Indian J Psychol Med Case Report A 32-year-old man, diagnosed with catatonic schizophrenia, was treated with risperidone and lorazepam in the general hospital psychiatry setup. He developed signs of intestinal obstruction, which was diagnosed as paralytic ileus and was treated conservatively along with stopping the offending drug. Risperidone is said to be devoid of anticholinergic side effects, but prevalence of these varies from 7% to 13% in patients receiving treatment for schizophrenia. Constipation has been reported but fatal adverse effect like paralytic ileus with risperidone is rarely reported. Timely diagnosis can save the need for surgical interventions and fatal complications. This predisposition in schizophrenia could be due to neurodevelopmentally shared abnormality of brain and gut nervous system. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3701367/ /pubmed/23833349 http://dx.doi.org/10.4103/0253-7176.112214 Text en Copyright: © Indian Journal of Psychological Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ramamourthy, Parthasarathy Kumaran, Arunkumar Kattimani, Shivanand Risperidone Associated Paralytic Ileus in Schizophrenia |
title | Risperidone Associated Paralytic Ileus in Schizophrenia |
title_full | Risperidone Associated Paralytic Ileus in Schizophrenia |
title_fullStr | Risperidone Associated Paralytic Ileus in Schizophrenia |
title_full_unstemmed | Risperidone Associated Paralytic Ileus in Schizophrenia |
title_short | Risperidone Associated Paralytic Ileus in Schizophrenia |
title_sort | risperidone associated paralytic ileus in schizophrenia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701367/ https://www.ncbi.nlm.nih.gov/pubmed/23833349 http://dx.doi.org/10.4103/0253-7176.112214 |
work_keys_str_mv | AT ramamourthyparthasarathy risperidoneassociatedparalyticileusinschizophrenia AT kumaranarunkumar risperidoneassociatedparalyticileusinschizophrenia AT kattimanishivanand risperidoneassociatedparalyticileusinschizophrenia |